Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,203 | 712 | 99.8% |
| Education | $19.66 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,597 | 115 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,016 | 54 | $0 (2024) |
| ABBVIE INC. | $788.20 | 54 | $0 (2024) |
| Lilly USA, LLC | $669.79 | 55 | $0 (2024) |
| Esperion Therapeutics, Inc. | $478.88 | 29 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $476.02 | 23 | $0 (2024) |
| PFIZER INC. | $463.64 | 38 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $459.81 | 27 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $422.93 | 26 | $0 (2024) |
| GlaxoSmithKline, LLC. | $405.50 | 28 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,578 | 218 | Amgen Inc. ($386.63) |
| 2023 | $2,543 | 147 | AbbVie Inc. ($294.02) |
| 2022 | $1,614 | 96 | Novo Nordisk Inc ($396.26) |
| 2021 | $986.94 | 66 | Novo Nordisk Inc ($240.11) |
| 2020 | $982.80 | 66 | AstraZeneca Pharmaceuticals LP ($217.57) |
| 2019 | $882.64 | 76 | PFIZER INC. ($165.16) |
| 2018 | $635.91 | 45 | Novo Nordisk Inc ($122.34) |
All Payment Transactions
714 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Gastroenterology | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Gastroenterology | ||||||
| 12/20/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/19/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: GALLSTONES | ||||||
| 12/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Cardio-renal | ||||||
| 12/16/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $1.90 | General |
| Category: Obesity | ||||||
| 12/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: RESPIRATORY | ||||||
| 12/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Obesity | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Inflammation | ||||||
| 12/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Cardio-renal | ||||||
| 12/02/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: Oncology | ||||||
| 12/02/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $10.15 | General |
| Category: Obesity | ||||||
| 11/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Biological | ||||||
| 11/21/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/21/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.77 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.68 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $7.85 | General |
| Category: Obesity | ||||||
| 11/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.42 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 839 | 1,753 | $456,429 | $109,754 |
| 2022 | 21 | 932 | 1,819 | $282,750 | $107,506 |
| 2021 | 16 | 586 | 1,102 | $176,881 | $69,996 |
| 2020 | 20 | 640 | 1,160 | $218,481 | $81,566 |
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 232 | 598 | $184,045 | $48,808 | 26.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 128 | 128 | $63,090 | $15,519 | 24.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 27 | 137 | $59,351 | $12,282 | 20.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 28 | 36 | $21,089 | $4,464 | 21.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 15 | 15 | $17,870 | $4,229 | 23.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 68 | $14,270 | $4,068 | 28.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 39 | 39 | $18,233 | $3,896 | 21.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 56 | 64 | $13,274 | $3,311 | 24.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 44 | 44 | $11,088 | $3,165 | 28.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 12 | 12 | $8,763 | $1,862 | 21.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 21 | 23 | $10,555 | $1,842 | 17.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 19 | 30 | $9,001 | $1,826 | 20.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 48 | 48 | $4,756 | $1,337 | 28.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 27 | 32 | $7,251 | $1,246 | 17.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 15 | 21 | $6,061 | $857.52 | 14.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 36 | 48 | $4,724 | $452.79 | 9.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $1,346 | $369.72 | 27.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 19 | 136 | $1,093 | $104.69 | 9.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 24 | 28 | $439.88 | $95.48 | 21.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 21 | 233 | $128.19 | $19.84 | 15.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 190 | 514 | $101,258 | $42,165 | 41.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 110 | 110 | $34,320 | $13,637 | 39.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 30 | 129 | $24,897 | $9,653 | 38.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 30 | 30 | $25,890 | $8,356 | 32.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 49 | 49 | $22,834 | $7,606 | 33.3% |
About Ramy Sayed
Ramy Sayed is a Pediatrics healthcare provider based in Smyrna, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/03/2013. The National Provider Identifier (NPI) number assigned to this provider is 1518398437.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ramy Sayed has received a total of $11,222 in payments from pharmaceutical and medical device companies, with $3,578 received in 2024. These payments were reported across 714 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($11,203).
As a Medicare-enrolled provider, Sayed has provided services to 2,997 Medicare beneficiaries, totaling 5,834 services with total Medicare billing of $368,821. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Practice Information
- Specialty Pediatrics
- Other Specialties Internal Medicine
- Location Smyrna, TN
- Active Since 12/03/2013
- Last Updated 11/17/2025
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1518398437
Products in Payments
- FARXIGA (Drug) $608.01
- REXULTI (Drug) $515.28
- Ozempic (Drug) $506.37
- Saxenda (Drug) $484.01
- NEXLETOL (Drug) $478.88
- JARDIANCE (Drug) $413.79
- MOUNJARO (Drug) $377.78
- VRAYLAR (Drug) $376.36
- XARELTO (Drug) $333.94
- TRINTELLIX (Drug) $323.30
- CeQur Simplicity (Device) $313.77
- TRELEGY ELLIPTA (Drug) $275.62
- CONTRAVE (Drug) $263.92
- XIFAXAN (Drug) $254.52
- Otezla (Drug) $236.19
- ENTRESTO (Drug) $234.24
- BREZTRI (Drug) $224.19
- Kerendia (Drug) $209.81
- LEQVIO (Drug) $188.69
- Rybelsus (Drug) $170.05
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Smyrna
Miss. Felisa Gilbert, Md, MD
Pediatrics — Payments: $3,772
Heather Phillips, Md, MD
Pediatrics — Payments: $3,194
Miss. Sarah-Jo Stimpson, M.d, M.D
Pediatrics — Payments: $2,474
Dr. Ma Caridad Rosal, M.d, M.D
Pediatrics — Payments: $2,464
Jennifer Liquido, M.d, M.D
Pediatrics — Payments: $2,389
Melissa Fuller, M.d, M.D
Pediatrics — Payments: $2,238